NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

Using 5% floor space of their factory and only for compassionate use, using their legacy hand made technology used for the clinical trials in that space. Their machines likely take up far less space than the clean rooms and as they were at the acquisition, made for small labs, they make 10 times the production per clean room. So the potential to scale is immense, and would likely improve over time as they go from machines to a full scale production facility that is totally automated, but the company will likely be sold and not have to scale that up beyond the many tens of thousands of doses they could likely make if they scaled up just this or facility even just with individual machines, though I think long-term they’d turn the facility into one giant “machine” with parallel processing of doses, using the space and technology more efficiently.

I think you do not understand this yet.